Guardant Health
GH • NASDAQ
Guardant Health is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Helmy Eltoukhy, with a market cap of $11.1B.
CEOHelmy Eltoukhy
Next Earnings
Upcoming earnings announcement for Guardant Health
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.58
Revenue Estimate
$278.9M
Earnings History
Past 12 earnings reports for Guardant Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Q4 2025 | -$0.50Est: -$0.61 | +18.0% | $281.3MEst: $275.4M | +2.1% |  10-K |
| Oct 29, 2025 | Q3 2025 | -$0.39Est: -$0.61 | +36.1% | $265.2MEst: $235.2M | +12.7% | 10-Q |
| Jul 30, 2025 | Q2 2025 | -$0.44Est: -$0.62 | +29.0% | $232.1MEst: $211.3M | +9.8% | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.49Est: -$0.59 | +16.9% | $203.5MEst: $190.0M | +7.1% | 10-Q |
| Feb 20, 2025 | Q4 2024 | -$0.62Est: -$0.50 | -24.0% | $201.8MEst: $192.5M | +4.8% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.45Est: -$0.74 | +39.2% | $191.5MEst: $170.6M | +12.2% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.48Est: -$0.75 | +36.0% | $177.2MEst: $162.7M | +9.0% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.46Est: -$0.85 | +45.9% | $168.5MEst: $150.7M | +11.8% | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$0.64Est: -$0.87 | +26.4% | $155.1MEst: $149.6M | +3.7% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.67Est: -$0.95 | +29.5% | $143.0MEst: $137.4M | +4.1% | — |
| Aug 3, 2023 | Q2 2023 | -$0.82Est: -$1.18 | +30.5% | $137.2MEst: $129.4M | +6.0% | 10-Q |
| May 9, 2023 | Q1 2023 | -$1.06Est: -$1.31 | +19.1% | $128.7MEst: $117.9M | +9.2% | — |